The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Mistletoe as complementary treatment in patients with advanced non-small cell lung cancer treated with carboplatin-based combinations: A randomized phase II study.
Gil Bar-Sela
No relevant relationships to disclose
Mira Wollner
No relevant relationships to disclose
Liat Hammer
No relevant relationships to disclose
Abed Agbarya
No relevant relationships to disclose
Elizabeth Dudnik
No relevant relationships to disclose
Nissim Haim
No relevant relationships to disclose